The Need to Address AMR Burden During COVID-19 Times

  09 July 2020

As per the World Health Organisation, only a small proportion of COVID-19 patients need antibiotics to treat subsequent bacterial infections and has issued guidance not to provide antibiotic treatment to patients with mild COVID-19 illness. However, people are consuming high doses of antibiotics as a precautionary measure when they feel symptoms like fever, cold and cough, without acknowledging that this could lead to antimicrobial resistance (AMR).

Further reading: ET Health World
Author(s): Patrick R Murray
Effective Surveillance  
Back


Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market
  • Global reach for funding / co-development / licensing
Display your technology and make use of the Continuous AMR Partnering Initiative >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!